Effects of serotonin, of its biosynthetic precursors and of the anti-serotonin agent metergoline on the release of glucagon and insulin from rat pancreas
- PMID: 352887
- DOI: 10.1055/s-0028-1093434
Effects of serotonin, of its biosynthetic precursors and of the anti-serotonin agent metergoline on the release of glucagon and insulin from rat pancreas
Abstract
We have evaluated the effect of serotonin (5-HT) and of its biosynthetic precursors 5-Hydroxytryptophan (5-HTP) and tryptophan (TRP) on the release of immunoreactive glucagon (IRG) and insulin (IRI) from isolated islets and pieces of pancrease of the rat. In isolated islets, 5-HT inhibited the IRI response to a high glucose concentration (3.0 mg/ml), without affecting the IRG response to either a low (0.5 mg/ml) or a high glucose concentration; TRP stimulated the IRG and IRI response to the low glucose concentration, while 5-HTP was ineffective. When pieces of pancreas were used, 5-HT and 5-HTP inhibited IRG response to both glucose concentrations, while IRI release was inhibited only by 5-HT. The anti-5-HT agent metergoline enhanced the release of IRG and IRI by pieces of pancreas at both glucose concentrations. The results indicate that exogenous and endogenous 5-HT inhibit basal as well as glucose-mediated IRG and IRI release; that isolated islets are less sensitive than pieces of pancreas to the inhibitory effect of 5-HT and that TRP acts as an amino acid and not as a precursor of 5-HT.
Similar articles
-
Effects of histamine, of histidine and of anti-histaminic agents on the release of glucagon and insulin from the rat pancreas.Horm Metab Res. 1979 Feb;11(2):100-3. doi: 10.1055/s-0028-1092688. Horm Metab Res. 1979. PMID: 374215
-
Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas.J Clin Invest. 1974 Oct;54(4):833-41. doi: 10.1172/JCI107823. J Clin Invest. 1974. PMID: 4430717 Free PMC article.
-
Reversal of somatostatin inhibition of insulin and glucagon secretion.Diabetes. 1976 Nov;25(11):1031-40. doi: 10.2337/diab.25.11.1031. Diabetes. 1976. PMID: 992224
-
Serotonergic regulation of insulin secretion.Acta Physiol (Oxf). 2019 Jan;225(1):e13101. doi: 10.1111/apha.13101. Epub 2018 Jun 20. Acta Physiol (Oxf). 2019. PMID: 29791774 Review.
-
Control of pancreatic IRG secretion in vivo.Metabolism. 1976 Nov;25(11 Suppl 1):1437-41. doi: 10.1016/s0026-0495(76)80160-6. Metabolism. 1976. PMID: 790089 Review. No abstract available.
Cited by
-
Serotonin Influences Insulin Secretion in Rat Insulinoma INS-1E Cells.Int J Mol Sci. 2024 Jun 21;25(13):6828. doi: 10.3390/ijms25136828. Int J Mol Sci. 2024. PMID: 38999937 Free PMC article.
-
Improved oral glucose tolerance following antiserotonin treatment in patients with chemical diabetes.Eur J Clin Pharmacol. 1979 Jul;15(6):395-9. doi: 10.1007/BF00561737. Eur J Clin Pharmacol. 1979. PMID: 499287 Clinical Trial.
-
Targeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes.Diabetes. 2021 Dec;70(12):2721-2732. doi: 10.2337/dbi20-0048. Diabetes. 2021. PMID: 34872936 Free PMC article. Review.
-
Biogenic amine regulation of glucagon secretion.Acta Diabetol Lat. 1984 Oct-Dec;21(4):333-40. doi: 10.1007/BF02582086. Acta Diabetol Lat. 1984. PMID: 6397023
-
Possible role of glucagon in cyproheptadine-induced increase of insulin secretion.Acta Diabetol Lat. 1982 Jul-Sep;19(3):219-26. doi: 10.1007/BF02624681. Acta Diabetol Lat. 1982. PMID: 6756004
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources